🇺🇸 FDA
Patent

US 6316190

Oligonucleotides which specifically bind retroviral nucleocapsid proteins

expired A61KA61K47/54A61K47/549

Quick answer

US patent 6316190 (Oligonucleotides which specifically bind retroviral nucleocapsid proteins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K47/54, A61K47/549